Healthcare | November 21, 2024
Emcure and MS Dhoni drive India’s fight against Anemia
Emcure has launched an awareness campaign to help spread the word about male anemia
Emcure has launched an awareness campaign to help spread the word about male anemia
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Genomics is transforming the future of modern medicine and treatment modalities across specialties
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Subscribe To Our Newsletter & Stay Updated
